Having cut its teeth by automating the dental insurance claims process, Overjet is now ready to extend its artificial intelligence software to actual dental clinics across the United States.
These plans will be backed by a freshly issued FDA clearance for Overjet’s dental assist platform and a flood of venture capital funds gleaned from a recently closed round.
The funding grossed $ 27 million for the Boston-based startup, nearly quadrupling its lifespan following previous fundraisers totaling around $ 10 million. Series A was led by General Catalyst and Insight Partners, with additional support from the E14 Fund, which provides funds to startups linked to the Massachusetts Institute of Technology.
Overjet’s plans for the windfall are twofold: The money will support Overjet’s goal of bringing its existing platform to dental clinics across the country, while also funding the development of new tools and systems based on AI aimed at improving the field of dentistry.
RELATED: Overjet Gets FDA Clearance for Gum Disease Detection Deep Learning Software
The flagship feature of the Dental Assist program is the deep learning-based technology that can perform real-time analyzes of dental x-rays. AI is trained to measure bone loss in these images, making it easier for dentists and hygienists to diagnose periodontal disease, which affects nearly half of all American adults and, in severe untreated cases, can cause pain and loss of teeth.
The program is designed to dramatically reduce the time between imaging and diagnosis as it operates in real time and eliminates the need for dentists to manually study x-rays to measure bone levels.
Additionally, long before the FDA cleared its clinical use, Dental Assist was used by insurers to analyze x-rays submitted alongside claims, improving the accuracy of their approval process.
“Tens of millions of Americans are already seeing the processing of their dental claims streamlined and accelerated thanks to Overjet” noted Shaju Puthussery, COO of Overjet. âWith recent FDA clearance and new funding, more Americans will see Overjet’s dental AI technology assisting their dentists at their next check-up. We are committed to helping clinicians provide the best patient care.
RELATED: Using Bioluminescent Protein to Map Active Tooth Decay, Calcivis Gets FDA Blessing
FDA 510 (k) clearance for the Dental Assist platform in May made it one of the first AI systems to receive the green light for use in dentistry and only came in about three years. after the founding of Overjet by scientists from MIT and the Harvard School of Dentistry.
The agency’s nod came after a clinical study proved the platform to be highly skilled at measuring bone density in oral x-rays. Compared to estimates from several dentists and an oral radiologist, AI measurements on average aligned with those of humans to within a third of a millimeter.
Going forward, Overjet hopes to receive further clearances from the FDA to extend the scope of AI beyond gum disease, allowing the software to identify and assess cavities, tartar, impacted teeth. and other dental problems.